Christine G Kohn Selected Research

Pain (Aches)

12/2018

Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine G Kohn Research Topics

Disease

5	Hemorrhage 01/2020 - 01/2014
4	Neoplasms (Cancer) 01/2020 - 12/2016
4	Stable Angina 12/2018 - 03/2014
3	Venous Thromboembolism 02/2019 - 08/2014
3	Coronary Disease (Coronary Heart Disease) 12/2018 - 04/2014
2	Thrombosis (Thrombus) 01/2020 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 12/2018 - 01/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 12/2017
2	Pulmonary Embolism 01/2017 - 10/2016
2	Breast Neoplasms (Breast Cancer) 11/2016 - 01/2016
1	Urogenital Neoplasms 01/2020
1	Thromboembolism 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Chronic Disease (Chronic Diseases) 06/2019
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2019
1	Pain (Aches) 12/2018
1	Ventricular Tachycardia 05/2018
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2018
1	Ischemic Stroke 01/2018
1	Melanoma (Melanoma, Malignant) 04/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2016
1	Colonic Neoplasms (Colon Cancer) 12/2016
1	Disease Progression 01/2016
1	Hypoglycemia (Reactive Hypoglycemia) 01/2015
1	Weight Gain 01/2015
1	Angina Pectoris 04/2014
1	Atrial Fibrillation 01/2014

Drug/Important Bio-Agent (IBA)

5	RivaroxabanIBA 01/2020 - 10/2016
4	Ranolazine FDA Link 12/2018 - 03/2014
3	Vitamin K FDA Link 01/2017 - 01/2014
2	Warfarin (Coumadin)FDA LinkGeneric 02/2019 - 10/2016
2	AnticoagulantsIBA 01/2018 - 08/2014
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Factor Xa InhibitorsIBA 01/2020
1	Biosimilar PharmaceuticalsIBA 06/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018
1	NivolumabIBA 04/2017
1	pembrolizumabIBA 04/2017
1	Immune Checkpoint InhibitorsIBA 04/2017
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2017
1	RamucirumabIBA 12/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016
1	Heparin (Liquaemin)FDA LinkGeneric 10/2016
1	human ERBB2 proteinIBA 01/2016
1	miglitol (Glyset)FDA Link 01/2015
1	alogliptinIBA 01/2015
1	empagliflozinIBA 01/2015
1	Insulin Glargine (Lantus)FDA Link 01/2015
1	LinagliptinIBA 01/2015
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2015
1	Pioglitazone (Actos)FDA Link 01/2015
1	Nateglinide (Starlix)FDA LinkGeneric 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015
1	Metformin (Glucophage)FDA LinkGeneric 01/2015
1	SodiumIBA 01/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2015
1	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2014
1	MetalsIBA 01/2013

Therapy/Procedure

7	Therapeutics 01/2018 - 01/2013
2	Length of Stay 01/2017 - 10/2016
1	Defibrillators (Defibrillator) 05/2018
1	Thrombectomy 01/2018
1	Hospice Care (Care, Bereavement) 01/2018
1	Secondary Prevention 01/2018
1	Drug Therapy (Chemotherapy) 12/2017
1	Stents 01/2013